You can buy or sell RLMD and other stocks, options, ETFs, and crypto commission-free!
Relmada Therapeutics, Inc. Common Stock, also called Relmada Therapeutics, is a clinical-stage biotechnology company. Read More It engages in the development of d-methadone receptor antagonist, which is a chemical entity that addresses areas of high unmet medical need in the treatment of central nervous system diseases and other disorders. The company was founded on May 31, 2012 and is headquartered in New York, NY.
New York, New York
52 Week High
52 Week Low